# Readiness Delta 0.4.2

## Readiness posture

0.4.2 improves software readiness by making the runtime controller 10k evidence lane bounded and reproducible. ClinicalTestReady, ClinicalSubmissionReady, and PreclinicalEvidenceComplete remain blocked.

## Improved readiness evidence

- Normal build and active CTest lane can complete without relying on the disabled long-readiness tests.
- The runtime controller 10k path now has a bounded default mode and an explicit full-mode environment switch.
- Clinical-readiness reporting recognizes generated HIL artifacts and reports HIL risk coverage status.

## Remaining blockers

- Runtime bounded projection evidence is not full 10k execution evidence.
- HIL coverage must reach 18/18 hazards covered or formally justified.
- Physical HIL evidence, phantom qualification, named independent sign-off, cybersecurity execution evidence, and Canada/US package reviews remain required.

## Evidence artifacts to separate in 0.4.3

- `qms/generated/Runtime10kBoundedEvidence.md`
- `qms/generated/Runtime10kFullEvidence.md`
- `qms/hil/session_reports/HIL-SESSION-0.4.3.md`
- `qms/hil/risk_coverage/HIL-RISK-COVERAGE-0.4.3.csv`
- `qms/hil/latency_reports/HIL-LATENCY-0.4.3.md`

## Readiness conclusion

0.4.2 is an improvement over scaffold-only evidence, but it must remain blocked from clinical-test claims until the 0.4.3 evidence separation/versioning work and later physical/sign-off evidence are completed.
